Leelyn Smith, LLC Eli Lilly & CO Transaction History

Leelyn Smith, LLC

$543 Million
Q3 2024

A detailed history of Leelyn Smith, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Leelyn Smith, LLC holds 8,232 shares of LLY stock, worth $6.55 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

8,232

Previous 8,609 4.38%

Holding current value

$6.55 Million

Previous $7.79 Million 6.43%

% of portfolio

1.34%

Previous 1.51%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $291,096 - $361,927	-377 Reduced 4.38%	8,232 $7.29 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $451,594 - $566,331	-623 Reduced 6.75%	8,609 $7.79 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $431,121 - $576,779	-728 Reduced 7.31%	9,232 $7.18 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $228,982 - $269,940	-436 Reduced 4.19%	9,960 $5.81 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $748,553 - $1.03 Million	-1,722 Reduced 14.21%	10,396 $5.58 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $148,012 - $197,909	-422 Reduced 3.37%	12,118 $5.68 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $123,009 - $144,468	396 Added 3.26%	12,540 $4.31 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $322,193 - $375,419	1,002 Added 8.99%	12,144 $4.44 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $718,964 - $819,334	-2,425 Reduced 17.87%	11,142 $3.6 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $85,848 - $100,799	-308 Reduced 2.22%	13,567 $4.4 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $179,303 - $222,828	764 Added 5.83%	13,875 $3.97 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $14,390 - $17,858	-64 Reduced 0.49%	13,111 $3.62 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $87,753 - $107,993	396 Added 3.1%	13,175 $3.04 Million
Q2 2021 Aug 31, 2021	SELL	$180.55 - $233.54 $64,636 - $83,607	-358 Reduced 2.73%	12,779 $2.93 Million
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $167,442 - $216,761	1,019 Added 8.41%	13,137 $2.45 Million
Q4 2020 Jan 15, 2021	BUY	$130.46 - $172.63 $1.54 Million - $2.04 Million	11,810 Added 3834.42%	12,118 $2.03 Million
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $2,728 - $3,283	20 Added 6.94%	308 $51,000
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $357 - $442	-3 Reduced 1.03%	288 $40,000
Q4 2019 Feb 06, 2020	BUY	$106.92 - $132.43 $31,113 - $38,537	291 New	291 $38,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leelyn Smith, LLC with notifications on news.

Account